We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INOV
2826
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$351K ﹤0.01%
+13,286
New +$311K
INO icon
2827
Inovio Pharmaceuticals
INO
$93M
$350K ﹤0.01%
2,511
+459
+22% +$95.7K
SLGL icon
2828
Sol-Gel Technologies
SLGL
$275M
$350K ﹤0.01%
4,828
+648
+16% +$49.8K
TCBI icon
2829
Texas Capital Bancshares
TCBI
$4.38B
$350K ﹤0.01%
11,244
-26,331
-70% -$831K
WK icon
2830
Workiva
WK
$4.01B
$350K ﹤0.01%
6,280
ATRC icon
2831
AtriCure
ATRC
$2.21B
$349K ﹤0.01%
+8,736
New +$370K
EUHY
2832
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$246M
$349K ﹤0.01%
+6,681
New +$349K
RWK icon
2833
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
$349K ﹤0.01%
6,456
-2,560
-28% -$140K
SOLN
2834
DELISTED
The Southern Company
SOLN
$349K ﹤0.01%
7,500
ATH
2835
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$349K ﹤0.01%
+10,252
New +$353K
CLOV icon
2836
Clover Health Investments
CLOV
$2.38B
$347K ﹤0.01%
27,822
+10,105
+57% +$112K
PBR icon
2837
Petrobras
PBR
$115B
$347K ﹤0.01%
48,751
+21,914
+82% +$186K
QCRH icon
2838
QCR Holdings
QCRH
$1.75B
$347K ﹤0.01%
12,675
STC icon
2839
Stewart Information Services
STC
$2.07B
$347K ﹤0.01%
+7,933
New +$321K
MCA
2840
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$347K ﹤0.01%
24,161
-942
-4% -$13.8K
GRFS
2841
Grifois
GRFS
$5.4B
$343K ﹤0.01%
19,746
+1,432
+8% +$25.3K
MTA
2842
Metalla Royalty & Streaming
MTA
$848M
$343K ﹤0.01%
+43,700
New +$338K
HIW icon
2843
Highwoods Properties
HIW
$3.51B
$341K ﹤0.01%
10,146
-2,398
-19% -$88.3K
NIO icon
2844
CALL
NIO
NIO
$11.3B
$341K ﹤0.01%
29,800
-200
-0.7% -$3.08K
SEM
2845
DELISTED
Select Medical
SEM
$341K ﹤0.01%
+30,440
New +$300K
BSJO
2846
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
$341K ﹤0.01%
14,123
+551
+4% +$13.3K
XYLD icon
2847
Global X S&P 500 Covered Call ETF
XYLD
$3.28B
$340K ﹤0.01%
7,608
-480
-6% -$21.2K
PDM
2848
Piedmont Realty Trust
PDM
$1.2B
$337K ﹤0.01%
24,840
+5,077
+26% +$78.6K
FRGI
2849
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$337K ﹤0.01%
+36,000
New +$312K
SPFF icon
2850
Global X SuperIncome Preferred ETF
SPFF
$144M
$336K ﹤0.01%
30,361
+16
+0.1% +$176

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.